You searched for "ARN"
“She’s the Lewis Capaldi of the art world”: the young visually impaired artist transforming creativity
Hannah Evans (17) from Linlithgow, has been creating art since she was three years old and has three group exhibitions and three large solo shows under her belt. She is also partially sighted, autistic, and has specific learning and communication disabilities.Retina World Congress 2025
8 May 2025
-11 May 2025
As one of the largest retina meetings in the world, Retina World Congress is leading the advancement of science in retina. Its annual meeting brings together retina specialists from every continent to achieve a global scientific and clinical exchange in...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
Retina / Uvea / Vitreous
|
Diabetic macular edema (DME), Intravitreal ziv, aflibercept (IVZ), Neovascular age related macular degeneration (n, AMD), Ziv, aflibercept, retinal venous occlusion (RVO)
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
Subthreshold micropulse laser in BRVO
1 August 2019
| Saruban Pasu
|
Retina / Uvea / Vitreous
The purpose of this retrospective, consecutive, single-centre, non-randomised, and case-control study was to verify the therapeutic effects and safety of oedema (from branch retinal vein occlusion (BRVO)) recurrence suppression effect using 577-nm subthreshold micropulse laser photocoagulation (SMLP) in combination with...
Type 3 CNV and anti-VEGF
1 February 2019
| Saruban Pasu
|
Retina / Uvea / Vitreous
The purpose of the study was to determine the differences between aflibercept and ranibizumab in terms of their therapeutic efficacy in the treatment of Type 3 neovascularisation. The authors highlight that the dominant mechanism for Type 3 neovascularisation development is...
Effect of anti-VEGF treatment on PED morphology
1 June 2015
| Jaya Myneni
|
Retina / Uvea / Vitreous
|
Choroidal neovascularization, optical coherence tomography, ranibizumab, VEGF
This retrospective study of 30 eyes assessed the effect of anti-VEGF on morphology of pigment epithelial detachments (PED) secondary to age-related macular degeneration (AMD). Thirty eyes of 28 patients with PED were compared to 30 eyes of 30 patients with...
The impact of obstructive sleep apnoea monitoring functionality on smartwatches: a new frontier for ophthalmologists
3 June 2024
| Yu Jeat Chong, Matthew Azzopardi
|
Ophthalmology
Dawn of a new era in wearable technology? Smartwatches have really stepped up their game and have evolved from telling time to keeping an eye on our health. In February 2024, the United States Food and Drug Administration (FDA) gave...
Effect of long-term RGP-CL wear on keratoconus progression
This is a retrospective study between April and December 2017, of 22 rigid gas-permeable contact lens (RGP-CL) patients (31 eyes) and 15 non-CL patients (20 eyes) who fulfilled the criteria of: 1) >3 years follow-up and 2) Scheimpflug-based corneal imaging...Trabeculectomy ab interno (trabectome)
1 June 2016
| Sofia Rokerya
|
Glaucoma
This retrospective study examines the outcome of trabectome surgery in nine phakic patients with Posner-Schlossman syndrome with uncontrolled IOP >30mmgHg. Cytomegalovirus (CMV) DNA was verified by polymerase chain reaction (PCR) in aqueous humour samples. Patients were treated with oral valganciclover...
The rarebit vision test for macular conditions
1 October 2015
| Nana Theodorou
|
Retina / Uvea / Vitreous
|
age-related macular degeneration, macula, macular oedema, rarebit, vision test, visual acuity
Rarebit testing is used to measure low degrees of neuro-visual damage and is available for free on the internet. It consists of a fixed bright light dot presented on a black background. During testing it is presented briefly at different...
White dot syndromes
1 September 2015
| Gwyn Samuel Williams
|
Retina / Uvea / Vitreous
It is fair to say that trainees and consultants who are not medical retina specialists are a bit scared of the so called retinal ‘white dot syndromes’. It is easy to understand why this is the case, as almost every...